...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Vote reminder
2
Oct 19, 2023 12:50PM
1
Oct 21, 2023 11:04AM

Oct 22, 2023 10:41AM
4
Oct 22, 2023 04:03PM
3
Oct 23, 2023 11:05AM

Toinv
Anxious to get info from corporate - especially regarding the timetable to get these products to market and revenue generation. Expecting detailed, specific, concrete corporate plans and timetables. 
Is that too much to expect from Zenith leadership?

Chicagoest

5
Oct 24, 2023 10:07AM
3
Oct 24, 2023 10:22AM
Share
New Message
Please login to post a reply